FDA Approves ZOLEDRONIC ACID — Gland Pharma Limited

# FDA Approves Gland Pharma's Generic Zoledronic Acid Gland Pharma Limited has received FDA approval for its generic zoledronic acid intravenous formulation, expanding the competitive landscape for this widely-used bisphosphonate treatment for osteoporosis and bone metastases. The approval is expected to increase price competition and improve patient access to the treatment, though it adds pressure on existing branded and generic competitors in the bisphosphonate market.